coronavirus
cov
uniqu
encod
exoribonucleas
within
nonstructur
protein
requir
highfidel
replic
like
via
proofread
associ
cov
rnadepend
rna
polymeras
activ
enhanc
bind
small
nonenzymat
protein
howev
known
whether
function
regul
cov
replic
fidel
test
engin
singl
doubl
alanin
substitut
mutat
genom
murin
hepat
viru
contain
exon
activ
exon
posit
within
known
disrupt
interact
vitro
show
mutant
five
ten
time
sensit
treatment
rna
mutagen
wildtyp
wt
exon
suggest
decreas
replic
fidel
decreasedfidel
phenotyp
confirm
use
two
addit
nucleosid
analog
ribavirin
reach
peak
titer
similar
demonstr
rna
synthesi
kinet
compar
seen
wtexon
chang
sensit
observ
rel
mhvexon
indic
decreasedfidel
phenotyp
link
presenc
exon
activ
result
demonstr
import
cov
replic
fidel
support
hypothesi
function
regul
activ
viru
replic
adapt
capac
cov
well
rna
virus
partial
attribut
presenc
extens
popul
genet
divers
howev
decreas
fidel
detriment
cov
replic
virul
mutant
cov
decreas
replic
fidel
attenu
sensit
inhibit
rna
mutagen
thu
identifi
viral
protein
determin
cov
fidel
import
understand
cov
replic
pathogenesi
virul
report
show
small
nonenzymat
viral
protein
contribut
cov
replic
fidel
data
support
hypothesi
cov
evolv
multipl
protein
addit
respons
maintain
integr
largest
known
rna
genom
v
iral
adapt
driven
select
genet
bottleneck
present
within
host
transmiss
error
rate
fidel
viral
replicas
gener
genet
divers
subject
select
core
rna
viru
replicas
except
retrovirus
rnadepend
rna
polymeras
rdrp
research
perform
numer
rna
virus
includ
footandmouth
diseas
viru
polioviru
chikungunya
viru
influenza
viru
coxsackieviru
human
enteroviru
demonstr
mutat
within
viral
rdrp
either
increas
decreas
replicas
fidel
vast
major
case
alter
replic
fidel
result
decreas
viral
fit
attenu
virul
review
refer
also
virus
alter
replic
fidel
potenti
therapeut
valu
live
attenu
vaccin
togeth
observ
underscor
need
elucid
contribut
individu
proteinprotein
interact
virusencod
enzym
replicas
fidel
coronaviru
cov
replicas
complex
mani
rna
virus
due
larg
genom
presenc
multipl
rnamodifi
activ
addit
encod
rdrp
activ
within
nonstructur
protein
cov
encod
exoribonucleas
exon
activ
within
biochem
studi
shown
exon
capabl
remov
mismatch
inactiv
exon
activ
decreas
fidel
cov
replicas
tissu
cultur
vivo
virus
lack
exon
activ
exon
increas
suscept
lethal
mutagenesi
presenc
rna
mutagen
compar
wildtyp
wt
virus
contain
exon
activ
exon
thu
avail
bioinformat
biochem
virolog
data
support
conclus
cov
evolv
proofread
capac
attempt
reconstitut
cov
replicas
use
recombin
protein
imped
limit
polymeras
activ
observ
vitro
recent
work
subissi
et
al
demonstr
requir
process
rna
synthesi
cov
replic
part
increas
bind
rna
templat
also
capabl
associ
without
disrupt
capac
exon
cleav
rna
templat
asid
viral
protein
demonstr
affect
fidel
cov
replicas
small
cov
protein
known
enzymat
function
bind
enhanc
exon
activ
vitro
mutat
alter
interact
vitro
reduc
abolish
enhanc
exon
activ
addit
enhanc
exon
activ
alloster
regul
involv
cap
cov
rna
evas
host
interferon
ifn
stimul
gene
target
mutagenesi
studi
also
implic
critic
regul
cov
rna
synthesi
proteolyt
process
viral
proteas
studi
indic
essenti
compon
cov
replicas
directli
interact
affect
exon
activ
vitro
howev
known
whether
affect
fidel
cov
replicas
whether
affect
activ
viru
replic
show
mutat
murin
hepat
viru
posit
previous
demonstr
disrupt
interact
vitro
decreas
cov
replic
fidel
doubl
mutant
increas
sensit
base
nucleosid
analog
aza
ribavirin
rbv
compar
wtexon
indic
decreas
fidel
substitut
introduc
mhvexon
increas
sensit
beyond
mhvexon
result
demonstr
mutat
decreas
cov
fidel
support
hypothesi
fidel
depend
intact
exon
activ
result
consist
recent
biochem
studi
support
model
cov
use
multipl
nonstructur
protein
includ
faith
replic
larg
rna
genom
cell
cultur
delay
brain
tumor
murin
astrocytoma
clone
cell
maintain
dulbecco
modifi
eagl
medium
dmem
gibco
supplement
fetal
bovin
serum
fb
invitrogen
uml
penicillin
streptomycin
gibco
mm
hepe
gml
amphotericin
b
corn
babi
hamster
kidney
bhk
cell
stabli
express
mhv
receptor
bhkr
maintain
medium
supplement
mgml
mediatech
sitedirect
mutagenesi
reduc
number
downstream
sequenc
reaction
region
mhv
e
fragment
posit
contain
subclon
ta
vector
invitrogen
accord
manufactur
instruct
twentyf
nanogram
templat
use
introduc
point
mutat
within
quikchang
stratagen
sitedirect
mutagenesi
perform
accord
manufactur
protocol
mutant
gener
similarli
except
mutagenesi
perform
use
f
fragment
plasmid
sequenc
genhunt
corpor
nashvil
tn
ensur
intend
mutat
present
confirm
fragment
contain
excis
topo
use
bamhi
kpni
ligat
wt
e
fragment
linear
bamhi
kpni
assembl
recoveri
virus
infecti
cdna
clone
genbank
access
describ
previous
briefli
total
g
linear
wt
mhv
fragment
fragment
f
g
ligat
togeth
appropri
e
fragment
contain
mutat
overnight
use
ligas
new
england
biolab
exon
virus
f
fragment
contain
two
exon
mutat
use
volum
sodium
acet
ph
volum
chloroform
ad
ligat
reaction
aqueou
layer
remov
new
tube
volum
isopropanol
ad
precipit
dna
purifi
product
resuspend
nucleasefre
water
transcrib
use
ambion
mmessag
mmachin
follow
modif
total
reaction
volum
l
l
mm
gtp
l
ntpcap
l
reaction
buffer
l
templat
l
enzym
mix
reaction
modifi
order
effici
gener
longer
transcript
min
h
min
min
min
transcript
n
gene
gener
use
water
instead
mm
gtp
fifti
microlit
transcript
reaction
l
n
transcript
electropor
biorad
genepuls
xcell
bhkr
cell
ad
flask
seed
cell
cell
grown
flask
contain
viru
frozen
cytopath
effect
cpe
present
throughout
flask
flask
thaw
debri
pellet
g
sorval
rc
plu
rotor
min
supernat
divid
aliquot
consid
passag
stock
viru
titer
determin
plaqu
assay
use
cell
describ
previous
propag
confirm
recombin
virus
subconflu
cell
infect
multipl
infect
moi
pfucel
gener
stock
viru
harvest
describ
ensur
recov
virus
contain
intend
mutat
rna
harvest
cell
infect
stock
use
trizol
ambion
rna
purifi
accord
manufactur
protocol
revers
transcrib
rt
use
superscript
iii
invitrogen
describ
previous
virus
entir
code
region
sequenc
ensur
absenc
addit
mutat
stock
sequenc
across
entir
genom
ensur
mutat
arisen
recoveri
fullgenom
sequenc
overlap
cdna
amplicon
gener
use
l
rt
product
total
reaction
volum
l
contain
ng
forward
revers
primer
l
reaction
buffer
l
mm
deoxynucleosid
triphosph
dntp
l
ul
highfidel
easi
polymeras
agil
pcr
perform
use
biorad
touch
thermal
cycler
follow
step
min
step
step
step
min
step
min
step
repeat
time
primer
gener
singl
band
column
purifi
use
wizard
sv
gel
pcr
cleanup
system
promega
nucleotid
sequenc
amplicon
sequenc
primer
avail
upon
request
base
nucleosid
analog
sensit
studi
aza
ribavirin
rbv
purchas
sigma
stock
solut
made
dimethyl
sulfoxid
dmso
mm
water
mm
water
mm
respect
sensit
studi
perform
indic
concentr
base
nucleosid
analog
low
pfucel
high
pfucel
moi
infect
describ
previous
sensit
experi
cell
shift
appropri
temperatur
treatment
ad
back
postinfect
demonstr
rbv
exhibit
minim
cellular
toxic
cell
concentr
cytotox
aza
rbv
concentr
determin
use
celltiterglo
promega
accord
manufactur
instruct
briefli
cell
seed
opaqu
tissueculturegrad
plate
approxim
h
prior
addit
aza
rbv
cell
incub
aza
rbv
indic
concentr
h
cell
viabil
determin
replic
curv
rna
synthesi
kinet
viral
replic
kinet
determin
high
moi
pfucel
low
moi
pfucel
describ
previous
supernat
l
collect
indic
time
point
viru
titer
determin
plaqu
assay
kinet
genom
subgenom
rna
synthesi
moi
pfucel
without
treatment
determin
twostep
realtim
quantit
rtpcr
qrtpcr
use
rna
harvest
time
indic
rna
extract
trizol
rt
reaction
perform
describ
primer
use
detect
genom
subgenom
n
rna
well
gapdh
dehydrogenas
previous
report
region
use
quantifi
genom
rna
level
overlap
mutat
introduc
within
reaction
data
analysi
perform
describ
previous
modif
rt
product
dilut
valu
determin
duplic
well
sampl
averag
one
valu
minim
welltowel
variat
data
normal
rel
gapdh
use
threshold
cycl
method
sensit
assay
subconflu
monolay
cell
plate
pretreat
either
uml
uml
mous
beta
interferon
pbl
assay
scienc
piscataway
nj
h
prior
infect
pretreat
reaction
mixtur
remov
monolay
inocul
indic
viru
moi
pfucel
min
inoculum
remov
fresh
dmem
ad
well
supernat
harvest
h
postinfect
viru
titer
determin
plaqu
assay
statist
analysi
statist
test
appli
note
use
graphpad
prism
la
jolla
ca
softwar
signific
denot
p
p
p
determin
use
test
describ
figur
legend
case
data
normal
untreat
control
also
perform
use
graphpad
prism
number
replic
sampl
denot
within
figur
legend
test
role
fidel
engin
mutat
code
alanin
substitut
infecti
clone
conserv
amino
acid
posit
report
disrupt
sever
acut
respiratori
syndrom
sar
cov
interact
vitro
sarscov
sarscov
fig
except
mutat
mutat
permit
viru
recoveri
earlier
attempt
anoth
group
recov
also
unsuccess
previous
demonstr
base
analog
incorpor
cov
genom
viral
replic
result
increas
genom
mutat
incorpor
increas
lowfidel
virus
lack
exon
activ
exon
indic
viru
sensit
treatment
use
test
decreas
replic
fidel
compar
replic
singl
alanin
substitut
mutant
wtexon
presenc
absenc
three
mutant
virus
exhibit
sensit
phenotyp
similar
wtexon
viru
moi
pfucel
moi
pfucel
fig
b
exhibit
toxic
cell
concentr
format
stabl
complex
like
involv
multipl
surfaceexpos
residu
substitut
one
posit
might
suffici
alter
interact
viru
infect
thu
introduc
alanin
doubl
substitut
within
test
whether
alanin
doubl
substitut
affect
viru
sensit
treatment
increas
sensit
detect
infect
moi
pfucel
fig
infect
higher
moi
could
mask
subtl
increas
sensit
due
capac
popul
toler
complement
mutat
thu
examin
sensit
treatment
low
moi
pfucel
demonstr
increas
sensit
treatment
compar
wtexon
fig
sensit
concentr
depend
across
rang
test
demonstr
subtl
increas
sensit
focus
primarili
viru
subsequ
experi
data
demonstr
mutat
increas
sensit
consist
decreas
replic
fidel
data
also
indic
impact
mutat
fidel
less
seen
inactiv
exon
activ
titer
mhvexon
decreas
almost
log
follow
treatment
fig
show
increas
sensit
nucleosid
analog
aza
rbv
confirm
observ
sensit
result
decreas
fidel
test
whether
sensit
nucleosid
analog
aza
ribavirin
rbv
aza
rbv
shown
induc
mutagenesi
rna
viru
genom
recent
influenza
viru
examin
sensit
aza
rbv
infect
low
moi
pfucel
mhvexon
show
increas
sensit
aza
compar
wtexon
concentr
fig
sensit
aza
treatment
wtexon
mhvexon
undetect
plaqu
assay
concentr
consist
strong
mutat
phenotyp
sinc
aza
also
inhibit
wtexon
replic
exhibit
cellular
toxic
fig
examin
sensit
three
virus
guanosin
analog
rbv
previous
show
mhvexon
wtexon
sensit
treatment
rbv
consist
previou
data
rbv
show
minim
cytotox
concentr
effect
wtexon
titer
fig
mhvexon
undetect
plaqu
assay
rbv
concentr
sensit
rbv
treatment
wtexon
higher
concentr
result
indic
substitut
decreas
cov
replic
fidel
level
seen
wtexon
mhvexon
replic
rna
synthesi
kinet
mutant
determin
impact
mutat
infect
examin
replic
kinet
compar
wtexon
mhvexon
replic
kinet
similar
seen
wtexon
infect
moi
pfucel
fig
b
though
viru
titer
lower
wtexon
earli
time
point
enzymat
activ
report
predict
howev
mutat
report
impact
viral
rna
synthesi
therefor
measur
genom
subgenom
rna
level
mutant
infect
moi
pfucel
use
twostep
qrtpcr
genom
subgenom
rna
level
normal
endogen
gapdh
control
measur
presenc
absenc
treatment
wtexon
demonstr
similar
rna
synthesi
kinet
rna
accumul
affect
treatment
fig
basi
data
conclud
increas
sensit
due
impair
viral
rna
synthesi
increas
sensit
addit
stimul
activ
bind
requir
sarscov
omt
activ
sarscov
lack
activ
display
increas
sensit
exogen
interferon
beta
treatment
due
increas
recognit
host
interferonstimul
gene
dual
function
test
whether
display
increas
sensit
posit
control
engin
recov
alanin
substitut
mutat
mutat
abolish
sarscov
activ
render
sarscov
sensit
exogen
treatment
follow
treatment
viru
titer
reduc
approxim
log
fig
contrast
titer
wtexon
reduc
approxim
log
result
demonstr
substitut
significantli
impact
activ
measur
sensit
treatment
substitut
enhanc
sensit
mhvexon
treatment
phenotyp
result
alter
interact
demonstr
previou
biochem
studi
introduct
mutat
mhvexon
background
increas
sensit
beyond
mhvexon
test
examin
sensit
mhvexon
treatment
low
moi
pfucel
describ
substitut
within
result
increas
sensit
treatment
fig
compar
mhvexon
consist
observ
function
stimulatori
factor
data
indic
decreasedfidel
phenotyp
depend
upon
presenc
intact
exon
activ
sensit
increas
mechan
stimul
activ
unknown
basi
result
previou
biochem
studi
hypothes
function
stabil
regul
associ
compon
replic
complex
test
hypothesi
sought
stress
proteinprotein
interact
increas
temperatur
perform
sensit
experi
absenc
titer
wtexon
decreas
approxim
log
infect
compar
fig
indic
temperatur
sensit
follow
treatment
either
titer
wtexon
decreas
rel
treatment
fig
contrast
wtexon
result
viru
titer
decreas
almost
presenc
fig
combin
data
suggest
mutat
disrupt
proteinprotein
interact
potenti
necessari
cov
replic
fidel
recent
data
demonstr
multipl
cov
nsp
requir
process
rna
replic
interact
complex
combin
data
previou
studi
show
capac
enhanc
activ
involv
cov
rna
synthesi
data
suggest
core
compon
cov
replicas
show
mutat
within
posit
previous
shown
disrupt
sarscov
interact
vitro
led
decreas
replic
fidel
fig
cours
studi
bouvet
et
al
report
extens
panel
sarscov
mutat
disrupt
interact
two
mutat
could
recov
author
observ
increas
viru
sensit
treatment
data
consist
phenotyp
singl
mutant
fig
suggest
singl
point
mutat
within
might
suffici
disrupt
interact
viru
replic
con
trast
result
studi
perform
use
transient
transfect
recombin
singl
point
mutat
capabl
disrupt
interact
howev
differ
previou
studi
probabl
due
absenc
cov
replicas
protein
replicas
stabil
like
determin
network
proteinprotein
interact
involv
surfac
multipl
cov
nsp
thu
slight
decreas
strength
interact
might
compens
proteinprotein
interact
data
support
hypothesi
phenotyp
due
modul
exon
activ
display
rna
synthesi
kinet
similar
wtexon
fig
exhibit
increas
sensit
compar
wtexon
fig
indic
substitut
impact
activ
importantli
introduct
substitut
genom
lack
exon
activ
increas
viru
sensit
treatment
fig
compar
seen
mhvexon
analog
escherichia
coli
dna
polymeras
iii
pol
iii
could
function
stabil
enhanc
remov
termin
mismatch
viru
replic
drive
associ
replicas
compon
dna
pol
iii
holoenzym
contain
least
subunit
catalyt
site
compos
heterotrimer
polymeras
core
polymeras
exonucleas
subunit
recent
review
refer
subunit
small
protein
known
enzymat
function
shown
enhanc
proofread
activ
stabil
thermal
inactiv
condit
howev
depend
upon
presenc
subunit
exon
activ
first
report
independ
demonstr
requir
enzymat
activ
contrast
sarscov
interact
bind
requir
activ
affin
rna
report
howev
presenc
two
zinc
finger
znf
domain
within
coupl
capac
bind
rna
suggest
could
recruit
rna
report
enhanc
activ
howev
interact
could
conceiv
dictat
whether
function
primarili
viral
rna
cap
fidel
uncharacter
function
increas
sensit
observ
indic
fidel
like
decreas
elev
temperatur
fig
requir
cov
replic
unlik
phenotyp
observ
due
temperaturedepend
misfold
interpret
support
lack
temperatur
sensit
compar
wtexon
fig
elev
temperatur
could
disrupt
associ
thu
either
exert
direct
effect
activ
affect
rate
associ
replicas
complex
addit
phenotyp
could
due
destabil
absenc
develop
reagent
examin
detect
express
tissu
cultur
critic
resolv
import
issu
result
studi
identifi
determin
cov
replic
fidel
support
model
cov
use
multipl
nonstructur
protein
faith
replic
larg
rna
genom
data
also
indic
mechan
cov
regul
fidel
might
similar
dnabas
organ
could
repres
minim
unit
rna
synthesi
would
primari
determin
replic
fidel
abil
test
function
replic
viru
recapitul
put
complex
biochem
critic
mechanist
understand
cov
replic
thank
nicol
sexton
critic
review
manuscript
xiaotao
lu
technic
assist
grate
member
denison
laboratori
craig
cameron
penn
state
univers
help
discuss
work
support
unit
state
public
health
servic
award
titer
follow
replic
moi
pfucel
either
absenc
shown
viru
titer
statist
differ
wtexon
viru
titer
either
temperatur
determin
twotail
unpair
test
n
b
viru
sensit
treatment
either
shown
cell
pretreat
indic
concentr
infect
moi
pfucel
dmem
contain
dmso
ad
back
cell
incub
either
h
postinfect
supernat
harvest
viru
titer
determin
plaqu
assay
data
present
mean
sem
statist
signific
result
comparison
viru
titer
determin
p
p
p
use
twotail
unpair
test
n
